Navigation Links
SironRX Therapeutics Raises $3.4 Million Series A
Date:8/16/2011

CLEVELAND, Aug. 16, 2011 /PRNewswire/ -- SironRX Therapeutics, a biotechnology company developing novel regenerative therapies to accelerate dermal and bone healing, announced today a $3.4 million Series A investment led by North Coast Angel Fund.  Additional investors include Cleveland Clinic, JumpStart Inc., Fletcher Spaght Investments, Glengary LLC, Ohio Tech Angel Fund III, Early Stage Partners, X Gen Ltd. and a significant number of individuals.  

(Logo: http://photos.prnewswire.com/prnh/20110816/DC52317LOGO)

"We are excited to have secured this financing from a strong investor syndicate that includes both venture capitalists and angel investors," states Rahul Aras, Ph.D., who is SironRX's co-founder, President and CEO. "We will use the funds to build the SironRX team and execute on key clinical-stage milestones."

SironRX has exclusively licensed JVS-100 in the fields of dermal and bone repair from Juventas Therapeutics.  JVS-100 encodes Stromal cell-Derived Factor 1 (SDF-1), a naturally occurring factor that activates the body's own repair processes.  Juventas is developing JVS-100 for treatment of cardiovascular disease and recently completed a successful Phase I clinical trial demonstrating safety and preliminary efficacy in Class III heart failure patients.

"While the SDF-1 repair biology is well-conserved in nearly all end-organ systems, including the heart, skin and bone, the final product formulations, delivery and target clinical indications will differ significantly between the two companies," indicates Marc Penn, M.D., Ph.D., SironRX's Co-Founder and Chief Scientific Officer and Director of Research for the Summa Cardiovascular Institute.  "Separating the companies allows each to develop SDF-1 for very different market segments in a focused and orderly way."

SironRX will undertake its initial clinical trials to evaluate
'/>"/>

SOURCE SironRX Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Novel Flavonoid Compounds That Significantly Reduce Cancer Cell Growth Are Available For Further Research and Development as Anti-Cancer Therapeutics
2. United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
3. Peloton Therapeutics Completes $18 Million Series A Financing
4. United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011
5. Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment
6. Oxygen Healthcare (O2h) Announces Expanded Chemistry Collaboration With Heptares Therapeutics
7. Dr. Andrew Scharenberg, M.D., to Serve as Chief Scientific Officer for Cellectis therapeutics
8. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
9. Amsterdam Molecular Therapeutics Files Glybera® European Marketing Application for Re-examination
10. Amsterdam Molecular Therapeutics Appoints Dr. Carlos R. Camozzi as Chief Medical Officer
11. Sorrento Therapeutics Innovative Approach to Developing Vaccines and Therapeutics for MRSA Receives Continued Support From the National Institute of Allergy and Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... Ernst & Young LLP ("EY") that it was resigning effective ... delivered to the Company on September 15, 2014 and reported ... PDL has issued the following statement in response ... of inquiries on the reason for the resignation of EY.  ...
(Date:9/17/2014)... -- The global consumption of squalene / squalane is expected ... skin-identical chemical that finds applications in various end user industries ... in other applications like high grade lubrication, and fiber coating ... players and is regionally segregated. Sophim ( France ... ( Japan ), SeaDragon Marine Oils Ltd. ( ...
(Date:9/17/2014)... TRIANGLE PARK, N.C. , Sept. 17, 2014 /PRNewswire/ ... and presentation topics that will be featured at the ... Hamner Conference Center on December 3 and 4, 2014. ... managers are invited to hear the following: ... PhD UC San Diego Skaggs School of ...
(Date:9/17/2014)... Shimadzu Scientific Instruments introduces ... which offers a powerful separation method for ... provides a new level of knowledge and ... to scientists analyzing pharmaceutical impurities, proteins, lipids, ... Comprehensive 2D-LC combines two independent separation modes ...
Breaking Biology Technology:PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3In Silico Drug Discovery Conference Announces Speakers and Topics 2In Silico Drug Discovery Conference Announces Speakers and Topics 3In Silico Drug Discovery Conference Announces Speakers and Topics 4In Silico Drug Discovery Conference Announces Speakers and Topics 5In Silico Drug Discovery Conference Announces Speakers and Topics 6In Silico Drug Discovery Conference Announces Speakers and Topics 7Shimadzu’s New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph Empowers Laboratories to Separate Even the Most Complex Mixtures 2
... NEW YORK, Sept. 25 Bion Environmental Technologies,Inc. (OTC ... its patent application entitled, "Low Oxygen Organic Waste,Bioconversion System" ... and given a Standard Patent number of 2002227224. The,official ... the patent will be,in force until an expiration date ...
... for Neptune Technologies ... in FUNCTIONAL FOOD market-- ... ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) reported today,that it entered a worldwide ... with Weider Global Nutrition for the distribution,of dietary supplements and ...
... Osteotech, Inc.,(Nasdaq: OSTE ), a leader in ... today the appointment of Cato T.,Laurencin, M.D., Ph.D. to ... Directors effective September 24, 2008 and will serve on ... of Directors., Kenneth P. Fallon, III, Chairman of ...
Cached Biology Technology:Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment 2Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 2Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 3Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 4Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors 2
(Date:9/18/2014)... racial and ethnic groups describe losing eyesight as ... life, more so than other conditions including: loss ... African-Americans, 49% of non-Hispanic whites, 43% of Asians ... or ailment is the worst that could happen ... by AIDS/HIV. Hispanics and Asians ranked cancer ...
(Date:9/18/2014)... algal forests in the eastern Mediterranean Sea pose a ... distribution continues to expand as the climate warms, a ... of researchers led by Dr Adriana Vergs of UNSW ... for Advanced Studies in Spain, is published in the ... surveyed more than 1000 kilometres of coastline in Turkey ...
(Date:9/18/2014)... that when people are too stressed they are often ... Brain Mind Institute (BMI) at EPFL have just highlighted ... chronic stress and the loss of social skills and ... a synaptic regulatory molecule in the brain. This was ... . , Carmen Sandi,s team went to look ...
Breaking Biology News(10 mins):Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Tropical fish a threat to Mediterranean Sea ecosystems 2How stress tears us apart 2
... Antonio Medical mycologists in The South Texas Center ... Biology at The University of Texas at San Antonio ... Valley Fever, a respiratory infection of humans, commonly called ... fungus. For the first time, the researchers ...
... is based on detecting short, repetitive DNA segments in ... such characteristic repeats. "With this method we are able ... genetic relationships. Furthermore, we can show how new pathogenic ... The results have now been published in the current ...
... New Orleans residents were told to evacuate days before the ... real extent of the devastation. Now researchers from ... reliable way to help predict the intensity of the next ... States. Their model, which analyzes cell phone signals, adds a ...
Cached Biology News:UTSA infectious disease researchers advancing vaccine against Valley fever 2The tiny difference in the genes of bacteria 2Hurricane Katrina: Phone home 2
... DIGIVIEW line of digital x-ray detectors from ... device complete with 12 to 16 bit ... of a photodiode array sensor with pixel ... are available in low x-ray energies (10-50 ...
The Odyssey Infrared Imaging System is a complete family of products that includes the Odyssey Imager, IRDye labeling reagents and Odyssey software for scan control and data analysis....
... System from KUBTEC is a dual capability system ... dimensional representation of the specimen under test. While ... X-ray images, the micro focus source also allows ... in standard 2D images. The 50 mm x ...
... the condition in which a lack of ... the various antioxidants. Oxidative stress appears ... several diseases, including artherosclerosis, chronic inflammatory diseases, ... antioxidant systems that are very important for ...
Biology Products: